Samsung Bioepis and Biogen Announce EMA Filing Acceptance of SB11, a Proposed Biosimilar Referencing Lucentis® (ranibizumab)GlobeNewsWire • 10/06/20
Alzheimer's Treatment Fast-Tracked By FDA — Is Biogen Stock A Buy?Investors Business Daily • 09/23/20
Biogen Inc. (BIIB) CEO Michel Vounatsos Presents at Morgan Stanley Global Healthcare Conference (Transcript)Seeking Alpha • 09/14/20
Biogen to Invest $250 Million in a 20-year Initiative to Eliminate its Use of Fossil Fuels and Improve Public HealthGlobeNewsWire • 09/14/20
New Data at ACTRIMS-ECTRIMS Meeting Showcase Safety and Efficacy of Biogen’s Industry-Leading MS PortfolioGlobeNewsWire • 09/11/20
New Biogen Data Presented at ACTRIMS-ECTRIMS Advance Understanding of Clinical and Health Disparities in MSGlobeNewsWire • 09/08/20